Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Firebrick Pharma Limited ABN/ARBN Financial year ended: 64 157 765 896 30 June 2026 ...
Appendix 4G
Filed with ASX ·
On 6ix: 6ix.com/news/appendix-4g-123
6ix hasn’t read this filing yet.
Firebrick Pharma Limited on 6ix
Earlier from Firebrick Pharma
- Corporate Governance Statement
- Cleansing Notice
- Application for quotation of securities - FRE
- Proposed issue of securities - FRE
- Investor Update
Later from Firebrick Pharma
- Appendix 4E and Annual Report 30 June 2026
- Notice of AGM and Closing Date for Director Nominations
- Firebrick receives $293,000 R&D Tax Incentive
- Firebrick announces USA Retail Launch Plan
- Firebrick Investor Update Presentation
Follow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma